NCT01574677View on ClinicalTrials.gov

Assessment of Septin9 Biomarker for Detection of Colorectal Cancer in Patients With Positive Fecal Immunochemical Test

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

June 30, 2012

Conditions
Colorectal Cancer
Trial Locations (2)

30300

Kaiser Permanente Georgia, Atlanta

97227

Kaiser Permanente Northwest, Portland

Sponsors

Lead Sponsor

Epigenomics, Inc
All Listed Sponsors
collaborator

Kaiser Permanente

OTHER

collaborator

Emory University

OTHER

lead

Epigenomics, Inc

INDUSTRY

NCT01574677 - Assessment of Septin9 Biomarker for Detection of Colorectal Cancer in Patients With Positive Fecal Immunochemical Test | Biotech Hunter | Biotech Hunter